Monday, April 22, 2013 9:51:05 AM
Feltl notes NVDQ released impressive interim results from the PILLAR II study at a dinner event late last week which it attended. Two posters were presented at the SAGES conference and Novadaq held a number of booth presentations by surgeons during the conference as well. Novadaq products were prominently featured in the Intuitive Surgical (ISRG) and LifeCell booths. Conversations with company personnel imply early activity on Luna is encouraging.
Read more: http://www.briefing.com/InPlayEq/InPlay/InPlayDual.htm#ixzz2RCR186yc
Under Creative Commons License: Attribution
Follow us: @Briefingcom on Twitter | Briefingcom on Facebook
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM